Who owns Dianthus Therapeutics, Inc. /DE/?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DNTH from SEC Form 13F filings across 276 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 276 institutions disclosed 67.4M shares of Dianthus Therapeutics, Inc. /DE/ worth $5.94B — about 117.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
276
13F holders
$5.94B
value, 2026 filers
117.6%
of shares outstanding (67.4M sh)
46
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DNTH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.6M | $753.1M | 0.0% | 14.9% | +4.3% |
| 2 | T. Rowe Price Investment Management, Inc. | 5.9M | $518.3M | 0.4% | 10.3% | +51.4% |
| 3 | BlackRock, Inc. | 4.4M | $386.5M | 0.0% | 7.7% | +6.4% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 3.0M | $264.7M | 0.0% | 5.2% | -6.9% |
| 5 | Fairmount Funds Management LLC | 2.5M | $223.4M | 14.0% | 4.4% | 0.0% |
| 6 | STATE STREET CORP | 2.5M | $223.1M | 0.0% | 4.4% | +7.5% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | $213.8M | 0.0% | 4.2% | +12.4% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.2M | $194.4M | 0.0% | 3.9% | -12.2% |
| 9 | Avidity Partners Management LP | 1.9M | $167.3M | 34.3% | 3.3% | -9.7% |
| 10 | Octagon Capital Advisors LP | 1.7M | $148.5M | 19.8% | 2.9% | -8.4% |
| 11 | TCG Crossover Management, LLC | 1.7M | $147.6M | 4.2% | 2.9% | 0.0% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.5M | $136.0M | 0.0% | 2.7% | +170.9% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $125.4M | 0.0% | 2.5% | +13.1% |
| 14 | FRED ALGER MANAGEMENT, LLC | 1.3M | $114.6M | 0.3% | 2.3% | -0.1% |
| 15 | UBS Group AG | 1.2M | $105.1M | 0.0% | 2.1% | +4.7% |
| 16 | JENNISON ASSOCIATES LLC | 1.2M | $101.4M | 0.1% | 2% | +12.8% |
| 17 | FRANKLIN TEMPLETON INC | 1.1M | $95.0M | 0.0% | 1.9% | +14.3% |
| 18 | Polar Capital Holdings Plc | 1.0M | $89.4M | 0.2% | 1.8% | -0.3% |
| 19 | DEERFIELD MANAGEMENT COMPANY, L.P. | 914,000 | $80.5M | 1.2% | 1.6% | -18.8% |
| 20 | BAKER BROS. ADVISORS LP | 852,164 | $75.0M | 0.4% | 1.5% | 0.0% |
| 21 | Venrock Adviser, LLC | 822,020 | $72.4M | 3.5% | 1.4% | -30.3% |
| 22 | ALLIANCEBERNSTEIN L.P. | 821,034 | $72.3M | 0.0% | 1.4% | -1.6% |
| 23 | GOLDMAN SACHS GROUP INC | 774,811 | $68.2M | 0.0% | 1.4% | +102.7% |
| 24 | Assenagon Asset Management S.A. | 732,246 | $64.5M | 0.1% | 1.3% | +160.9% |
| 25 | CITADEL ADVISORS LLC | 629,225 | $55.4M | 0.0% | 1.1% | -35.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.